CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project addresses the challenge of multidrug-resistant bacteria by exploring new antibiotic strategies. It employs a systems biology approach to investigate the mechanisms of antibiotic penetration and resistance, fostering collaboration across various scientific disciplines.
Multidrug resistant bacteria are now ubiquitous in both hospitals and the larger community.
Drug-resistant pathogens are becoming increasingly pervasive, for example, the resurrection of tuberculosis provides one ominous example highlighting the risk associated with evolved drug resistance.
Moreover, many pharmaceutical companies abandoned this field and no truly novel active antibacterial compounds are currently in clinical trials.
Obviously we need new antibacterial molecules and maybe, novel…
CONSTRUCTOR UNIVERSITY BREMEN GGMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Cagliari
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, St Andrews
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Newcastle Upon Tyne
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Frankfurt Am Main
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
